Patient Experiences Before and After Enfortumab Vedotin Neoadjuvant Treatment in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
Publication
, Conference
Flaig, T; Hepp, Z; Narayanan, S; Whyte, J; Johnson, N; Matsuda, T; Hoimes, C
Published in: VALUE IN HEALTH
2022
Duke Scholars
Published In
VALUE IN HEALTH
EISSN
1524-4733
ISSN
1098-3015
Publication Date
2022
Volume
25
Issue
12
Start / End Page
S400 / S400
Related Subject Headings
- Health Policy & Services
- 4407 Policy and administration
- 4203 Health services and systems
- 3801 Applied economics
- 1402 Applied Economics
- 1117 Public Health and Health Services
Citation
APA
Chicago
ICMJE
MLA
NLM
Flaig, T., Hepp, Z., Narayanan, S., Whyte, J., Johnson, N., Matsuda, T., & Hoimes, C. (2022). Patient Experiences Before and After Enfortumab Vedotin Neoadjuvant Treatment in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer. In VALUE IN HEALTH (Vol. 25, pp. S400–S400).
Flaig, T., Z. Hepp, S. Narayanan, J. Whyte, N. Johnson, T. Matsuda, and C. Hoimes. “Patient Experiences Before and After Enfortumab Vedotin Neoadjuvant Treatment in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer.” In VALUE IN HEALTH, 25:S400–S400, 2022.
Flaig T, Hepp Z, Narayanan S, Whyte J, Johnson N, Matsuda T, et al. Patient Experiences Before and After Enfortumab Vedotin Neoadjuvant Treatment in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer. In: VALUE IN HEALTH. 2022. p. S400–S400.
Flaig, T., et al. “Patient Experiences Before and After Enfortumab Vedotin Neoadjuvant Treatment in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer.” VALUE IN HEALTH, vol. 25, no. 12, 2022, pp. S400–S400.
Flaig T, Hepp Z, Narayanan S, Whyte J, Johnson N, Matsuda T, Hoimes C. Patient Experiences Before and After Enfortumab Vedotin Neoadjuvant Treatment in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer. VALUE IN HEALTH. 2022. p. S400–S400.
Published In
VALUE IN HEALTH
EISSN
1524-4733
ISSN
1098-3015
Publication Date
2022
Volume
25
Issue
12
Start / End Page
S400 / S400
Related Subject Headings
- Health Policy & Services
- 4407 Policy and administration
- 4203 Health services and systems
- 3801 Applied economics
- 1402 Applied Economics
- 1117 Public Health and Health Services